China’s Mindray Refutes Merit Of Report That Sent Stock Plummeting

Mindray stock recovers from freefall after allegations that China’s leading medical device company overstated its earnings and engaged in fraudulent accounting practices.

Mindray Medical International Ltd. categorically denied allegations released in a Dec. 12 short seller’s report that alleged the company overstated its earnings and misled investors about cash on hand and its accounting practices.

The Shenzhen, China-based company held a conference call with analysts Dec. 13 to deny the report, which it said “contain[s] numerous errors of facts, misleading speculations and malicious interpretations of...

More from Asia

More from Geography